IDEXX reported quarterly revenue of 1,214,237 thousand dollars, up 9.9%, and income from operations of 402,348 thousand dollars, up 13.4%. Organic revenue grew 10.0%, led by higher recurring revenue volumes and realized prices.
IDXX · Idexx Laboratories Inc · Documents
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
IDEX Laboratories reported third-quarter organic revenue growth of 10% and EPS of $4.01, up 18% as reported, and raised its 2026 revenue outlook to $4,741,000,000 to $4,767,000,000 and EPS outlook to $14.96 to $15.16 per share.
IDEXX Laboratories reported third-quarter revenue of $1,214 million, up 10%, and diluted EPS of $4.01, up 18%, as it raised 2026 revenue guidance to $4,741 million - $4,767 million and EPS outlook to $14.96 - $15.16.